Nancy E. Kemeny
About
Nancy E. Kemeny is a scholar working on Oncology, Hepatology and Surgery.
According to data from OpenAlex, Nancy E. Kemeny has authored 370 papers receiving a total of 25.1k indexed citations (citations by other indexed papers that have themselves been cited), including 271 papers in Oncology, 196 papers in Hepatology and 157 papers in Surgery. Recurrent topics in Nancy E. Kemeny's work include Hepatocellular Carcinoma Treatment and Prognosis (191 papers), Colorectal Cancer Treatments and Studies (177 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (103 papers). Nancy E. Kemeny is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (191 papers), Colorectal Cancer Treatments and Studies (177 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (103 papers). Nancy E. Kemeny collaborates with scholars based in United States, Netherlands and Canada. Nancy E. Kemeny's co-authors include Yuman Fong, William R. Jarnagin, Mithat Gönen, Ronald P. DeMatteo, Leonard B. Saltz, Leslie H. Blumgart, Michael I. D’Angelica, Michael I. D’Angelica, Robert C. Bast and Gershon Y. Locker and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Nancy E. Kemeny
359 papers receiving 24.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Nancy E. Kemeny United States | 81 | 16.5k | 9.5k | 8.1k | 6.6k | 3.2k | 370 | 25.1k | ||
| Al B. Benson United States | 94 | 18.9k 1.1× | 5.8k 0.6× | 8.7k 1.1× | 8.7k 1.3× | 3.5k 1.1× | 492 | 31.0k | ||
| Timothy M. Pawlik United States | 79 | 13.6k 0.8× | 7.2k 0.8× | 11.6k 1.4× | 8.0k 1.2× | 2.2k 0.7× | 946 | 26.2k | ||
| Armando Santoro Italy | 87 | 17.8k 1.1× | 5.4k 0.6× | 3.8k 0.5× | 13.8k 2.1× | 5.6k 1.7× | 924 | 34.7k | ||
| Michel Ducreux France | 91 | 26.0k 1.6× | 8.7k 0.9× | 11.8k 1.5× | 10.7k 1.6× | 4.6k 1.4× | 628 | 38.9k | ||
| Cathy Eng United States | 61 | 10.8k 0.7× | 4.2k 0.4× | 6.3k 0.8× | 3.9k 0.6× | 2.2k 0.7× | 409 | 16.2k | ||
| Bengt Glimelius Sweden | 92 | 30.4k 1.8× | 3.5k 0.4× | 18.0k 2.2× | 9.9k 1.5× | 3.4k 1.1× | 700 | 41.7k | ||
| Richard M. Goldberg United States | 85 | 24.0k 1.5× | 4.1k 0.4× | 6.9k 0.9× | 8.3k 1.3× | 5.0k 1.6× | 531 | 33.3k | ||
| Alan P. Venook United States | 67 | 9.8k 0.6× | 5.2k 0.5× | 3.5k 0.4× | 3.8k 0.6× | 3.1k 1.0× | 365 | 17.5k | ||
| Filippo de Braud Italy | 74 | 17.9k 1.1× | 2.5k 0.3× | 5.6k 0.7× | 8.8k 1.3× | 5.7k 1.8× | 754 | 26.7k | ||
| Norihiro Kokudo Japan | 80 | 7.3k 0.4× | 16.4k 1.7× | 12.5k 1.6× | 5.8k 0.9× | 1.8k 0.6× | 727 | 26.0k |
Countries citing papers authored by Nancy E. Kemeny
Since
Specialization
Citations
This map shows the geographic impact of Nancy E. Kemeny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy E. Kemeny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy E. Kemeny more than expected).
Fields of papers citing papers by Nancy E. Kemeny
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Nancy E. Kemeny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy E. Kemeny. The network helps show where Nancy E. Kemeny may publish in the future.
Co-authorship network of co-authors of Nancy E. Kemeny
This figure shows the co-authorship network connecting the top 25 collaborators of Nancy E. Kemeny. A scholar is included among the top collaborators of Nancy E. Kemeny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy E. Kemeny. Nancy E. Kemeny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Connell, Louise C. & Nancy E. Kemeny. (2024). Intraarterial Chemotherapy for Liver Metastases. Hematology/Oncology Clinics of North America. 39(1). 143–159.
2.
Romesser, Paul B., Lara Hilal, John Cuaron, et al.. (2023). Radiation Therapy for Colorectal Liver Metastasis: The Effect of Radiation Therapy Dose and Chemotherapy on Local Control and Survival. Advances in Radiation Oncology. 9(2). 101382–101382.
3.
Rao, Devika, et al.. (2023). Case-Based Clinical Guidance on Dosing and Management of the Hepatic Artery Infusion Chemotherapy Pump. JCO Oncology Practice. 20(2). 187–194.
4.
Soares, Kevin C., Joshua S. Jolissaint, Kenneth Seier, et al.. (2023). Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival. Cancer Medicine. 12(11). 12272–12284.
5.
Vakiani, Efsevia, Mithat Gönen, Nancy E. Kemeny, et al.. (2022). Biopsy and Margins Optimize Outcomes after Thermal Ablation of Colorectal Liver Metastases. Cancers. 14(3). 693–693.
6.
Ecker, Brett L., Lily V. Saadat, Thomas Aparicio, et al.. (2022). Recurrence-free survival versus overall survival as a primary endpoint for studies of resected colorectal liver metastasis: a retrospective study and meta-analysis. The Lancet Oncology. 23(10). 1332–1342.
7.
Jolissaint, Joshua S., Kevin C. Soares, Kenneth Seier, et al.. (2021). Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection. Clinical Cancer Research. 27(14). 4101–4108.
8.
Boerner, Thomas, Constantinos P. Zambirinis, Johan Gagnière, et al.. (2020). Early liver metastases after “failure” of adjuvant chemotherapy for stage III colorectal cancer: is there a role for additional adjuvant therapy?. HPB. 23(4). 601–608.
9.
Smith, J. Joshua, Walid K. Chatila, Francisco Sánchez-Vega, et al.. (2019). Genomic stratification beyond Ras/B‐Raf in colorectal liver metastasis patients treated with hepatic arterial infusion. Cancer Medicine. 8(15). 6538–6548.
10.
Yaeger, Rona, Andrea Cercek, Eileen M. O’Reilly, et al.. (2015). Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF -Mutant Metastatic Colorectal Cancer Patients. Clinical Cancer Research. 21(6). 1313–1320.
11.
Yopp, Adam C., Lawrence H. Schwartz, Nancy E. Kemeny, et al.. (2011). Antiangiogenic Therapy for Primary Liver Cancer: Correlation of Changes in Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Tissue Hypoxia Markers and Clinical Response. Annals of Surgical Oncology. 18(8). 2192–2199.
12.
Poultsides, George A., Elliot L. Servais, Leonard B. Saltz, et al.. (2009). Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment. Journal of Clinical Oncology. 27(20). 3379–3384.
13.
Kemeny, Nancy E., Marinela Capanu, Michael I. D’Angelica, et al.. (2009). Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. Annals of Oncology. 20(7). 1236–1241.
14.
Sharma, Sunil, Nancy E. Kemeny, David P. Kelsen, et al.. (2002). A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecan. Annals of Oncology. 13(7). 1067–1071.
15.
Kronawitter, Ursula, Nancy E. Kemeny, Robert T. Heelan, Farid Fata, & Yuman Fong. (1999). Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma. Cancer. 86(2). 229–235.
16.
Kronawitter, Ursula, Nancy E. Kemeny, Robert T. Heelan, Farid Fata, & Yuman Fong. (1999). Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma. Cancer. 86(2). 229–235.
17.
Kronawitter, Ursula, Nancy E. Kemeny, & Leslie H. Blumgart. (1997). Neutropenic enterocolitis in a patient with colorectal carcinoma. Cancer. 80(4). 656–660.
18.
Kronawitter, Ursula, Nancy E. Kemeny, & Leslie H. Blumgart. (1997). Neutropenic enterocolitis in a patient with colorectal carcinoma. Cancer. 80(4). 656–660.
19.
Jakubowski, Ann A. & Nancy E. Kemeny. (1988). Hypotension as a manifestation of cardiotoxicity in three patients receiving cisplatin and 5-fluorouracil. Cancer. 62(2). 266–269.
20.
Allen-Mersh, T G, Nancy E. Kemeny, Donna Niedzwiecki, Barbara A. Shurgot, & J.M. Daly. (1987). Significance of a fall in serum CEA concentration in patients treated with cytotoxic chemotherapy for disseminated colorectal cancer.. Gut. 28(12). 1625–1629.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Al B. Benson Breakdown of academic impact, for papers by Timothy M. Pawlik Breakdown of academic impact, for papers by Armando Santoro Breakdown of academic impact, for papers by Michel Ducreux Breakdown of academic impact, for papers by Cathy Eng Breakdown of academic impact, for papers by Bengt Glimelius Breakdown of academic impact, for papers by Richard M. Goldberg Breakdown of academic impact, for papers by Alan P. Venook Breakdown of academic impact, for papers by Filippo de Braud Breakdown of academic impact, for papers by Norihiro Kokudo